首页 | 本学科首页   官方微博 | 高级检索  
     


Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?
Authors:Francesco Locatelli  Pedro Aljama  Peter Barany  Bernard Canaud  Fernando Carrera  Kai-Uwe Eckardt  Iain C Macdougall  Alison Macleod  Walter H H?rl  Andrzej Wiecek  Stewart Cameron
Affiliation:1Department of Nephrology and Dialysis, A. Manzoni Hospital, Lecco, Italy, 2Hospital Universitario Reina Sofia, Servicio de Nefrologia, Cordoba, Spain, 3Division of Renal Medicine, Department of Clinical Science, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden, 4Department of Nephrology, Lapeyronie University Hospital, Montpellier, France, 5Department of Nephrology and Dialysis, Hospital SAMS, Lisbon, Portugal, 6Department of Nephrology and Medical Intensive Care, Charite, Humboldt University, Berlin, Germany, 7Department of Renal Medicine, King's College Hospital, London, UK, 8Department of Medicine and Therapeutics, University of Aberdeen Medical School, Aberdeen, UK, 9Department of Medicine III, Division of Nephrology and Dialysis, University of Vienna, Austria, 10Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian University Medical School, Katowice, Poland and 11Department of Nephrology and Transplantation, Guy's Campus, Guy's, St Thomas’ and King's Medical School, London, UK
Abstract:
Keywords:anaemia   antibodies   guidelines   pure red-cell aplasia   rHuEpo
本文献已被 Oxford 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号